Blue Goat CyberBlue Goat CyberSMMedical Device Cybersecurity
    Start here
    Services
    • Medical Device Cybersecurity Consulting
    • FDA Premarket Cybersecurity Package
    • Medical Device Penetration Testing Services
    • FDA Deficiency Response
    • FDA Postmarket Cybersecurity
    • Medical Device Threat Modeling
    • eSTAR Cybersecurity Documentation Support
    See all services
    Products

    Blue Goat products

    • GoatWatch logoGoatWatchSBOM risk management for medical devices
    About
    Resources

    Learn

    • Blog
    • Podcast
    • Webinars
    • Talks & workshops
    • Glossary
    • FAQs

    Playbooks & Tools

    • Guides
    • Playbooks (PDF)
    • Infographics
    • Interactive Tools

    Signals & Proof

    • Goat FeedNew
    • News
    • Medical Device Security News
    • The Goat's Weekly
    • Case Studies
    • Proof / Receipts
    All resources, topic hubs, & collections →
    ⌘K
    Book Strategy SessionHow to prepare →
    1. Home
    2. Services
    3. Current page
    Blue Goat Cyber

    Full-service medical device cybersecurity. We protect patients by securing connected medical devices from design through postmarket.

    275+ FDA submissions supported, zero cybersecurity rejections · Mission: 1,000 by 2028

    SDVOSB · Service-Disabled Veteran-Owned Small Business

    We sponsor 10 community projects →

    Services

    • FDA Premarket Cybersecurity Package
    • FDA Deficiency Response
    • Medical Device Threat Modeling
    • Medical Device Penetration Testing Services
    • FDA Postmarket Cybersecurity
    • All services →
    Services
    • FDA Premarket Cybersecurity Package
    • FDA Deficiency Response
    • Medical Device Threat Modeling
    • Medical Device Penetration Testing Services
    • FDA Postmarket Cybersecurity
    • All services →

    Company

    • About
    • Core values
    • Manifesto
    • Leadership
    • Why Us
    • Partners
    • Careers
    • Press
    • Press kit
    • Contact
    • Company overviewPDF
    Company
    • About
    • Core values
    • Manifesto
    • Leadership
    • Why Us
    • Partners
    • Careers
    • Press
    • Press kit
    • Contact
    • Company overviewPDF

    Resources

    • Blog
    • Guides
    • Podcast
    • Case studies
    • Monthly Pulse newsletter
    • All resources →
    Resources
    • Blog
    • Guides
    • Podcast
    • Case studies
    • Monthly Pulse newsletter
    • All resources →

    Get in touch

    • info@bluegoatcyber.com
    • 844-939-GOAT
    • Book a strategy session →
    • 1776 N Scottsdale Rd, Unit 727
      Scottsdale, AZ 85257Serving clients worldwide

    Follow

    © 2026 Blue Goat Cyber. All rights reserved.

    • Privacy
    • Terms
    • Cookies
    • Sitemap
    • Accessibility
    • CVD

    MedTech Cybersecurity · Since 2022

    FDA Cybersecurity

    FDA Cybersecurity for Medical Devices

    One senior US-based team for the whole FDA cybersecurity scope: design, submission, testing, deficiency response, and postmarket. Built to Section 524B and the February 3, 2026 premarket guidance.

    Direct answer

    FDA cybersecurity is the set of design, documentation, and testing evidence a medical device manufacturer uses to address Section 524B of the FD&C Act and the FDA's February 3, 2026 premarket cybersecurity guidance. It spans the full product lifecycle: a Secure Product Development Framework and threat model during design, an SBOM, optional VEX statements, and recommended penetration test evidence at submission, and vulnerability monitoring, coordinated disclosure, and patch delivery after clearance. Blue Goat Cyber owns that scope end to end for 510(k), De Novo, PMA, PDP, and HDE programs.

    Jump to

    • How teams engage us(4)
    • Services across the lifecycle
    • What FDA guidance recommends(9)
    • Cost and timeline
    • FDA cybersecurity FAQs(7)

    How teams engage us

    Four entry points, depending on where your device is today. Every one starts with a free 30-minute call with a senior engineer and a mutual NDA.

    Gap analysis

    You are not sure what the FDA will ask for.

    A senior engineer reviews your architecture and existing documentation against Section 524B and the February 2026 guidance, then returns a point-by-point gap list with the artifact that closes each one.

    Run the readiness check

    Design-phase support

    You are still building and want to avoid rework.

    We embed alongside your engineering team, set the security architecture and control selection, and build the SPDF into your existing QMSR or ISO 13485 processes before the code is frozen.

    Secure product design

    Submission package

    Your device is nearly done and the submission is next.

    We deliver the cybersecurity artifacts in your scope, formatted for the current eSTAR template and traceable back to the threat model and risk assessment.

    Premarket cybersecurity

    Deficiency response

    You already submitted and got an AI or hold letter.

    Point-by-point reviewer-ready responses inside your 180-day clock, with each response mapped to the reviewer comment and the specific Section 524B clause it answers.

    Deficiency response

    FDA cybersecurity services across the device lifecycle

    Each phase links to the service page that owns the work. Most manufacturers engage us for two or three of these at once.

    Design

    • Secure MedTech product designSecurity architecture, trust boundaries, cryptography and key management, secure boot and update strategy.
    • Medical device threat modelingSTRIDE threat model with data flow diagrams, multi-patient harm view, and updateability view, aligned to ANSI/AAMI SW96:2023 and ISO 14971.

    Submission

    • FDA premarket cybersecurityThe full 18-artifact package for 510(k), De Novo, PMA, PDP, and HDE, delivered eSTAR-ready under Section 524B(b)(1) through (3).
    • Medical device penetration testingDevice, firmware, wireless, cloud, and mobile attack surfaces tested by senior engineers, with findings traced to the threat model.
    • Medical device SBOM servicesSPDX or CycloneDX SBOM with CISA minimum elements, CVE mapping, VEX statements, and end-of-support dates.
    • FDA deficiency responseHold letters, refuse-to-accept decisions, and AI cybersecurity deficiencies closed on the first resubmission.

    Postmarket

    • FDA postmarket cybersecuritySBOM monitoring, coordinated vulnerability disclosure, threat monitoring, incident response, and patch validation as one annual engagement.
    • Postmarket SBOM and VEX monitoringContinuous component-to-CVE matching with triage in device context, so your team gets decisions instead of a raw feed.
    • Legacy device cybersecurityCleared devices built before Section 524B brought up to the current postmarket obligations without a full redesign.

    What FDA guidance recommends, in reviewer order

    The cybersecurity evidence a reviewer looks for, and whether it belongs to the premarket submission, the postmarket program, or both.

    ArtifactWhat it containsPhase
    Security architecture viewsGlobal system, multi-patient harm, use case, and updateability viewsPremarket
    Threat modelSTRIDE analysis with assets, threat actors, attack paths, and safety impactPremarket
    Security risk assessmentTraceability from vulnerability to control to residual risk under ISO 14971Premarket
    Cybersecurity controlsControls addressing the FDA risk control categories, with verification evidencePremarket
    SBOM plus VEXMachine-readable SBOM, support levels, end-of-support dates, CVE applicabilityBoth
    Testing evidencePenetration testing, fuzz testing, vulnerability scanning, and SCA reportsPremarket
    Cybersecurity management planMonitoring sources, response timelines, patch delivery, and disclosure policyBoth
    Cybersecurity labelingCustomer security guide, SBOM disclosure, and end-of-support communicationBoth
    Metrics and monitoringMeasures that show the controls stay effective after clearancePostmarket

    The full 18-artifact breakdown, with what each one has to prove, lives on the FDA premarket cybersecurity service page. For the underlying regulation, see our guide to FDA cybersecurity guidance and Section 524B requirements explained.

    Cost and timeline

    Every engagement is a fixed fee, quoted in writing within 24 hours of the discovery call. No hourly billing and no surprise change orders.

    Software-only device

    Fixed fee after scoping

    SaMD, cloud, and mobile scope. Typically 6 to 8 weeks to a submission-ready binder.

    Connected device

    Fixed fee after scoping

    Firmware, wireless, and cloud attack surfaces. Typically 8 to 10 weeks.

    Complex or PMA

    Fixed fee after scoping

    Multi-component systems, AI/ML, or PMA-class traceability depth. Scoped per program.

    Postmarket is priced separately as an annual engagement. Deficiency response is scoped against the letter.

    Free tools

    Find out where you stand in a few minutes.

    Check whether Section 524B applies to your device, then score your submission readiness against the current guidance.

    All free tools
    2 min

    Section 524B Applicability

    Cyber device - yes or no?

    Open tool
    2 min

    FDA Cyber Readiness Quiz

    7-question premarket score

    Open tool
    4 min

    eSTAR Cyber Checklist

    16 artifacts reviewers look for

    Open tool
    FAQ

    FDA cybersecurity FAQs

    Cybersecurity alerts and guides

    Goat's Weekly alerts

    Medical device advisories and safety communications, with links to original sources. An alert is a reason to assess applicability, not proof that your device is affected.

    • Goat Feed: medical device cybersecurity alerts
    • The Goat's Weekly: Medical Device Cybersecurity News Brief

    Threat modeling, eSTAR 7.1, and SBOM evidence

    Connect threats to controls and test evidence. Compare the CISA 2026 SBOM fields with the NTIA 2021 baseline the FDA still cites, plus its support fields. Guidance recommendations remain separate from statutory duties.

    • FDA Medical Device Threat Modeling Guide
    • eSTAR 7.1 Cybersecurity Documentation Guide
    • FDA SBOM Requirements for Medical Devices
    • CISA 2026 SBOM Checklist for Medical Devices
    • CISA vs FDA SBOM Checklist and Scoring Tool

    Fixed-fee engagement

    FDA cybersecurity services: deliverables, inputs, and exclusions

    Included work is defined in the signed proposal. These scope options are not automatic inclusions in every engagement.

    Fixed-fee deliverables

    • A proposal selecting the applicable premarket, testing, threat-modeling, SBOM, or deficiency-response deliverables.
    • Named documents and agreed security activities, with evidence mapping and manufacturer review requirements.

    Required inputs

    • Intended use, device architecture, pathway, existing cybersecurity evidence, FDA correspondence if applicable, and hazard context.
    • Engineering/regulatory owners, planned milestones, and test access if testing is selected.

    Exclusions and separate work

    • This is an overview of scope options, not automatic inclusion of every service. Individual work items and ongoing services are separately identified in the proposal.
    • General software verification and validation, clinical performance testing, and full QMS implementation or certification are outside Blue Goat's product cybersecurity scope.
    • The manufacturer retains engineering changes, clinical-risk evaluation, risk acceptance, release approval, and regulatory submission decisions. No regulatory outcome is promised.

    Pricing and scope changes

    A written fixed-fee quote after scoping. The proposal names deliverables, versions, assumptions, required inputs, exclusions, and agreed dates. Additional work requires a separately agreed scope change. Missing inputs, access restrictions, manufacturer fixes, and review feedback can affect delivery.

    FDA cybersecurity

    Talk to a senior engineer, not a sales rep.

    Free 30-minute call, mutual NDA signed first, and a fixed-fee quote within 24 hours. We will tell you straight if you do not need us.

    Book strategy sessionSee all services